Ensign Group, Inc (ENSG) FinancialsENSGEnsign Group, Inc

The Ensign Group, Inc. (ENSG) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medicaid, accounting for 38.4% of total sales, equivalent to $552.59M. Other significant revenue streams include Medicare and Managed care. Understanding this composition is critical for investors evaluating how ENSG navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, The Ensign Group, Inc. maintains a gross margin of 14.47%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 8.69%, while the net margin is 6.93%. These profitability ratios, combined with a Return on Equity (ROE) of 16.98%, provide a clear picture of how effectively ENSG converts its operational activities into shareholder value.

In the context of the broader market, ENSG competes directly with industry leaders such as FMS and DVA. With a market capitalization of $10.08B, it holds a significant position in the sector. When comparing efficiency, ENSG's gross margin of 14.47% stands against FMS's 26.95% and DVA's 27.98%. Such benchmarking helps identify whether The Ensign Group, Inc. is trading at a premium or discount relative to its financial performance.

Ensign Group has shown consistent revenue growth, with Q2 2026 revenue at $1.44 billion, an 18.0% increase year-over-year. The company also reported a GAAP net income of $99.7 million for Q2 2026, an 18.2% increase year-over-year, reflecting its strong operational performance.